News

Filter

Current filters:

NovartisBiotechnology

1 to 9 of 142 results

EC approves new indication for Novartis’ Jakavi

EC approves new indication for Novartis’ Jakavi

17-03-2015

The European Commission has approved Swiss pharma giant Novartis’ Jakavi (ruxolitinib) for the treatment…

BiotechnologyEuropeIncyte CorpJakafiJakaviNovartisOncologyRegulation

Second $50M milestone for Ophthotech under Fovista deal with Novartis

11-03-2015

US biotech firm Ophthotech says it has achieved a second $50 million enrollment milestone from Swiss…

BiotechnologyFinancialFovistaNovartisOphthalmicsOphthotechResearch

Prime Therapeutics welcomes FDA's approval of first biosimilar in USA, but says more clarity is needed

Prime Therapeutics welcomes FDA's approval of first biosimilar in USA, but says more clarity is needed

09-03-2015

Prime Therapeutics, a non-profit US pharmacy benefit manager serving more than 26 million members, has…

AmgenBiosimilarsBiotechnologyNeupogenNovartisOncologyRegulationSandozUSAZarxio

Arrowhead acquires Novartis' RNAi R&D portfolio

Arrowhead acquires Novartis' RNAi R&D portfolio

07-03-2015

USA-based nano-medicine developer Arrowhead Research Corp revealed on Thursday that it has acquired Swiss…

Arrowhead ResearchArrowhead Research CorpBiotechnologyLicensingNovartis

Sandoz’s Zarxio first biosimilar to be approved under new FDA pathway

Sandoz’s Zarxio first biosimilar to be approved under new FDA pathway

06-03-2015

Sandoz, the generics unit of Swiss pharma giant Novartis, today received approval from the US Food and…

AmgenBiosimilarsBiotechnologyNeupogenNovartisOncologyRegulationSandozUSAZarxioZarzio

AbbVie to acquire Pharmacyclics, aiming to create leading hematological oncology franchise

AbbVie to acquire Pharmacyclics, aiming to create leading hematological oncology franchise

05-03-2015

US drugmaker AbbVie revealed late yesterday that it has reached an agreement to acquire US biopharma…

AbbVieBiotechnologyHematologyImbruvicaJohnson & JohnsonMergers & AcquisitionsNovartisOncologyPharmacyclics

UK doctors call for approval of off-label use of Avastin for wet-AMD

UK doctors call for approval of off-label use of Avastin for wet-AMD

25-02-2015

Doctors in the UK are calling on health ministers and NHS England to intervene to make Swiss pharma giant…

AvastinBiotechnologyHealthcareLucentisNovartisOphthalmicsPricingRegulationRocheUK

Further approvals for ThromboGenics’ Jetrea

12-02-2015

Belgian biotech company ThromboGenics, which is focused on developing and commercializing innovative…

AlconArgentinaBiotechnologyIsraelJetreaNovartisOphthalmicsRegulationThromboGenics

1 to 9 of 142 results

Back to top